Teriparatide biosimilar (Biosidus)

特立帕肽生物类似药（Biosidus）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide biosimilar (Biosidus)
Drug Alias NameRecombinant teriparatide (Biosidus)特立帕肽生物仿制药（Biosidus）Teriparatide follow-on biologic (Biosidus)OsteofortilrhPTH (1-34) (Biosidus)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryArgentina
Original Approved Date2012/08/01
Country/TerritoryEcuadorArgentina
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiosidus
China Registration ClassN/A

Develop Information

Active CompaniesBiosidus
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeH05AA02
Related LinksN/A